일회용 국소음압폐쇄 요법 디바이스 시장 규모, 점유율과 동향 분석 보고서 : 유형별, 창상 유형별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Disposable Negative Pressure Wound Therapy Devices Market Summary

The global disposable negative pressure wound therapy devices market size was estimated at USD 596.22 million in 2025 and is projected to reach USD 1,317.96 million by 2033, growing at a CAGR of 10.42% from 2026 to 2033. The market is driven by the growing burden of chronic and surgical wounds, particularly those associated with diabetes, aging populations, and the increasing number of surgical procedures.

The shift toward home healthcare and outpatient treatment is further accelerating demand for portable, single-use negative pressure wound therapy (NPWT) systems that are easy to apply and require minimal maintenance. In addition, the need to reduce healthcare costs, hospital stays, and infection rates, along with ongoing technological improvements that enhance usability and patient comfort, continues to support strong market growth.

The rising prevalence of chronic and surgical wounds is a major driver of the disposable Negative Pressure Wound Therapy (NPWT) market, as conditions such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, and post-operative wounds require advanced and consistent wound management. Disposable NPWT devices support faster healing and reduced infection risk, making them suitable for both acute and long-term wound care. As surgical volumes and chronic disease incidence continue to increase, demand for efficient, easy-to-use NPWT solutions is accelerating across healthcare settings.

The increasing number of surgical procedures is a key driver of the disposable NPWT devices market, as effective post-operative wound management is crucial for reducing complications such as infections and delayed healing. Disposable NPWT systems are widely adopted for surgical incisions due to their ability to manage exudate, protect closed wounds, and support faster recovery. As surgical volumes continue to rise globally across orthopedic, cardiovascular, and general surgeries, demand for convenient, single-use NPWT solutions is increasing. According to the World Population Review, in 2024, the number of surgical procedures was approximately 2.0 million, while non-surgical procedures accounted for about 4.2 million cases.

Technological advancements are a key driver of the disposable Negative Pressure Wound Therapy (NPWT) devices market, as innovations have significantly improved ease of use, portability, and treatment effectiveness. Modern disposable NPWT systems feature lightweight designs, longer battery life, quieter operation, and simplified application, making them suitable for both clinical and home-care settings. In addition, improved dressing materials and pressure control technologies enhance wound healing outcomes, encouraging wider adoption among clinicians and patients.

For instance, in April 2024, Smith+Nephew, a global medical technology company, announced the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the U.S., designed as a patient-centric solution for chronic wound management. The lightweight and compact system can be easily worn or carried, features a discreet canister, and operates quietly to support patient comfort and minimize disruption to daily activities.

Global Disposable NPWT Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global disposable negative pressure wound therapy devices market report on the basis of type, wound type, end-use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Canister-based
• Canister-free
• Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
• Acute Wound
  • Surgical & Traumatic Wounds
  • Burns
  • Chronic Wound
• Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Other Chronic Wounds
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Home Healthcare
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Type
  • 1.1.2. Wound Type
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Disposable Negative Pressure Wound Therapy Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising Prevalence of Chronic Wounds
    • 3.2.1.2. Shift Toward Home Healthcare
    • 3.2.1.3. Technological Advancements
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High Initial Costs
    • 3.2.2.2. Competition from Alternatives
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expansion in Emerging Markets
    • 3.2.3.2. Integration with Digital Health
    • 3.2.3.3. Product Innovation
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Reimbursement Challenges
• 3.3. Disposable Negative Pressure Wound Therapy Devices Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Disposable Negative Pressure Wound Therapy Devices Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Disposable Negative Pressure Wound Therapy Devices Market: Type Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Disposable Negative Pressure Wound Therapy Devices Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Canister-Based
  • 4.4.1. Canister-based market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Canister-Free
  • 4.5.1. Canister-free market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Disposable Negative Pressure Wound Therapy Devices Market: Wound Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Disposable Negative Pressure Wound Therapy Devices Market: Wound Type Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Disposable Negative Pressure Wound Therapy Devices Market Size & Trend Analysis, by Wound Type 2021 to 2033 (USD Million)
• 5.4. Acute Wound
  • 5.4.1. Acute wound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Surgical & traumatic wounds
    • 5.4.2.1. Surgical & traumatic wounds market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Burns
    • 5.4.3.1. Burns market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Chronic Wound
  • 5.5.1. Chronic Wound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Diabetic foot ulcers
    • 5.5.2.1. Diabetic foot ulcers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Pressure ulcers
    • 5.5.3.1. Pressure ulcers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Venous leg ulcers
    • 5.5.4.1. Venous leg ulcers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.5. Other chronic wounds
    • 5.5.5.1. Other chronic wounds market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Disposable Negative Pressure Wound Therapy Devices Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Disposable Negative Pressure Wound Therapy Devices Market: End use Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Disposable Negative Pressure Wound Therapy Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Specialty Clinics
  • 6.5.1. Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Home Healthcare
  • 6.6.1. Home healthcare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Disposable Negative Pressure Wound Therapy Devices Market: Regional Estimates & Trend Analysis by Type, Wound Type and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Argentina disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East and Africa
  • 7.7.1. Middle East and Africa disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. South Africa disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Saudi Arabia disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. UAE disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait disposable negative pressure wound therapy devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2025
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Type Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. Smith & Nephew
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Convatec
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. DeRoyal Industries, Inc.
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Molnlycke Health Care AB
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Medela (Medaxis LLC)
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Solventum
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Cardinal Health
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Genadyne Biotechnologies, Inc.
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Pensar Medical ( Lion Street Medical, LLC)
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. Guard Medical
    • 8.5.16.1. Company overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product Benchmarking
    • 8.5.16.4. Strategic initiatives
  • 8.5.17. Sunmedic AB
    • 8.5.17.1. Company overview
    • 8.5.17.2. Financial performance
    • 8.5.17.3. Product Benchmarking
    • 8.5.17.4. Strategic initiatives
  • 8.5.18. Advanced Oxygen Therapy Inc.
    • 8.5.18.1. Company overview
    • 8.5.18.2. Financial performance
    • 8.5.18.3. Product Benchmarking
    • 8.5.18.4. Strategic initiatives